Navigation Links
Jazz Pharmaceuticals, Inc. Announces Submission of Complete Response to FDA Approvable Letter for LUVOX(R) CR
Date:1/31/2008

PDUFA Date Set for February 29, 2008

PALO ALTO, Calif., Jan. 31 /PRNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the submission of the response by Solvay Pharmaceuticals, Inc. to the FDA approvable letter for Once-A-Day LUVOX(R) CR (fluvoxamine maleate) Extended-Release Capsules. The FDA has notified Solvay Pharmaceuticals that the Agency considers this a complete, class 1 response and the PDUFA action date is February 29, 2008. Jazz Pharmaceuticals continues to expect to launch LUVOX CR in the United States during the first quarter of 2008, subject to FDA approval.

In an approvable letter received on December 21, 2007, the FDA requested additional information concerning a CMC issue. Jazz Pharmaceuticals and Solvay Pharmaceuticals believe that the response submitted to the FDA on December 28, 2007 fully addressed that CMC issue. The approvable letter did not raise any questions related to safety or efficacy of LUVOX CR and included the FDA's proposed labeling.

The NDA for LUVOX CR seeks marketing approval for the treatment of obsessions and compulsions in patients with obsessive compulsive disorder (OCD) and for the treatment of social anxiety disorder (SAD). LUVOX CR is an extended-release formulation of fluvoxamine maleate, a selective serotonin reuptake inhibitor.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on identifying, developing and commercializing innovative products to meet unmet medical needs in neurology and psychiatry. For further information, please visit

SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Acura Pharmaceuticals, Inc. Announces Approval to List Shares on NASDAQ and Effective Feb. 4, 2008 a New Trading Symbol: ACUR
2. Acura Pharmaceuticals, Inc. Announces Appointment of George K. Ross as Director
3. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
4. American Stock Exchange LLC to Delist Securities of Samaritan Pharmaceuticals, Inc.
5. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Threshold Pharmaceuticals, Inc.
6. Alseres Pharmaceuticals, Inc. to Present at New York Society of Security Analysts Conference
7. Keryx Biopharmaceuticals, Inc. Announces Poster Presentations Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) to be Presented at the Upcoming American Society of Hematology Meeting in Atlanta, Georgia
8. Acura Pharmaceuticals, Inc. Announces Implementation of Reverse Stock Split and New Trading Symbol: ACPH
9. Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results
10. Elan Pharmaceuticals, Inc. Licenses Software and Databases From GeneGo
11. Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... 2014 As kinship care continues to ... cannot live with their parents, emphasis on kinship care ... enhance services and supports for kinship caregivers and families. ... Kinship Care Conference is being held this week in ... practice, policy, program and service development for kinship caregivers, ...
(Date:9/17/2014)... reserved for the very healthy. Astronauts are selected ... and psychological standards to prepare them for any ... spaceflight, average people can now fly for enjoyment. ... information about what medical conditions or diseases should ... as most medical conditions have never been studied ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 People who struggle ... now head to http://www.perwickstrom.com and get the answer ... thing to point out, is that a business plan and ... they work together, commented Per Wickstrom. “The way I view ... by a business strategy which is part two.” , ...
(Date:9/17/2014)... Bioluminescence, nanoparticles, gene manipulation these sound like ... in fact, they are components of an exciting ... In preclinical animal models of metastatic prostate cancer, ... VCU Institute of Molecular Medicine and Johns Hopkins ... molecular imaging approach that could revolutionize doctors, ability ...
(Date:9/17/2014)... September 17, 2014 Catalent Pharma ... technologies and development solutions for drugs, biologics and ... OptiPact™, an integrated service and technology offer based ... provided from the company’s 450,000 sq. ft. Kansas ... ability to integrate optimal formulation, development, analytical expertise, ...
Breaking Medicine News(10 mins):Health News:Arizona’s Children Association Kinship Service Providers Invited to Present at the CWLA National Conference 2Health News:Space: The final frontier… open to the public 2Health News:Per Wickstrom’s Latest Blog Explores the Difference Between a Business Plan and a Business Strategy 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 2Health News:New non-invasive technique could revolutionize the imaging of metastatic cancer 3Health News:New OptiPact™ Technology Introduced by Catalent 2
... , PTs and PTAs listed as occupations that will "likely ... July 21 The nation,s aging population and expanded health care coverage ... Physical Therapy Association (APTA) as a new federal report (1) that presents ... next 5 to 10 years is released. , ...
... , MINNEAPOLIS and COLUMBUS, Ohio, ... MEDNETWorld.com (MEDNET), a leader in Nationwide Health ... with The Rubicon Group, eHealth Ohio, Bostech Corporation and ... (HPOC) Service enabling interoperable electronic exchange of clinical data ...
... 21 , , Rochester Medical Corporation ... on Thursday July 30, 2009. The Company will then hold a quarterly ... 3:30 p.m. central time (4:30 p.m. eastern time). , , ... at Rochester Medical,s website at www.rocm.com . To listen ...
... , ANDOVER, Mass., July 21 ... that serves the Texas Midwest area, finished its implementation of ... for advanced authentication. Following its enterprise roll-out of Sentillion,s ... Go to enable caregivers in its trauma center to use ...
... Texas, July 21 GVI Security Solutions, Inc. (OTC Bulletin ... featuring the complete Samsung Electronics line of products, announced that ... video surveillance solution for a North East pharmacy chain. , ... surveillance solution is based on GVI Samsung high performance/low light ...
... , , ... Advice Networks , the nation,s leading provider of physician ... state-of-the-art wireless broadband technology solution that delivers real-time health ... flat-screen monitors. Strategically located in the back office, medical ...
Cached Medicine News:Health News:President's Council Projects Growth For Physical Therapy Profession 2Health News:Partnership Collaborates on HIE for Interoperability of Electronic Health Records and Patient Data in Ohio 2Health News:Rochester Medical Announces Third Quarter 2009 Earnings Conference Call July 30, 2009 2Health News:Hendrick Health System Deploys Sentillion's Tap & Go Advanced Authentication Solution 2Health News:Hendrick Health System Deploys Sentillion's Tap & Go Advanced Authentication Solution 3Health News:GVI Security Solutions Samsung Video Surveillance Solution Selected by North East Pharmacy Chain 2Health News:Healthy Advice Networks Announces the Launch of PracticeWire; Technology to Deliver Real-time Healthcare Content to Physicians 2
(Date:9/17/2014)... 17, 2014 The ambulance equipment ... decade due to the recession, an unstable ... advancements. This BCC Research report analyzes present ... the ambulance and emergency medical services equipment ... hemorrhage control devices, equipment used for burn ...
(Date:9/17/2014)... , Sept. 17, 2014  Dr. Stephen ... the White House today for National Recovery Month, stars ... consumer advocates released today. Consumer advocates were also joined ... who spoke out after losing her fiancée because of ... the doctor had a history of crack cocaine abuse. ...
(Date:9/17/2014)... 17, 2014 /PRNewswire-iReach/ -- ChemImage announced today ... improvements in the development of imaging technology ... normal and diseased tissue that minimizes the ... procedures, lowers surgical costs and potentially enhances ... The clinical and scientific teams ...
Breaking Medicine Technology:Ambulance and Emergency Equipment: Global Markets 2Ambulance and Emergency Equipment: Global Markets 3Ambulance and Emergency Equipment: Global Markets 4Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 2Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 3Patient Outcomes Improve When Molecular Chemical Imaging Technology Is Used to Aid Robotic Surgical Procedures, According to New White Paper 2
... Calif., Dec. 5, 2011  Radient Pharmaceuticals Corporation  (OTCQX:RXPC) ... In Vitro Diagnostic (IVD) cancer test, announced ... the 2012 Gastrointestinal Cancers Symposium (ASCO Conference) were ... The meeting will be held on January 19-21, ...
... (NASDAQ and MTA: CTIC) announced today an update on ... application ("MAA") for Pixuvri. CTI is seeking a license ... relapsed or refractory aggressive non-Hodgkin,s lymphoma ("NHL") who have ... received the CHMP,s day 180 list of outstanding issues, ...
Cached Medicine Technology:Radient Pharmaceuticals' Two Abstracts Submitted to 2012 Gastrointestinal Cancers Symposium (ASCO) Regarding Onko-Sure® Utility in Colorectal Cancer Are Accepted for Presentation 2Radient Pharmaceuticals' Two Abstracts Submitted to 2012 Gastrointestinal Cancers Symposium (ASCO) Regarding Onko-Sure® Utility in Colorectal Cancer Are Accepted for Presentation 3European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012 2European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012 3European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012 4European Medicines Agency's (EMA) Committee for Human Medicinal Products (CHMP)Tentatively Scheduled to Render an Opinion on PixuvriTM Marketing Authorization Application on January 19, 2012 5
The CGIL iridectomy contact glass was designed by Riquin, Fankhauser et al. to perform full thickness peripheral laser iridectomies....
The CGVL vitrectomy contact glass was designed by Rol, Fankhauser et al. for photodisruptive YAG laser procedures in the posterior vitreous....
For newly born children 10 mm internal diameter of the cornea part. Designed to work with argon/YAG Lasers....
... The HAAG-STREIT OM 900 Ophthalmometer uses ... the three requirements of Helmholtz: 1. The ... of the distance between the Ophthalmometer and ... are independent of the distance between the ...
Medicine Products: